Naïve cells or cells overexpressing Rab4A-GFP were treated with each of the two compounds for 30 min prior to the treatment with aSyn monomers, and were then incubated together with aSyn for 24 h and processed for ICC or immunoblotting, as described above. This evidence concerns the gene RAB4A and intrahepatic cholangiocarcinoma.